EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics

Gangyin Zhao, Ye Zeng, Wanli Cheng, Sofia Karkampouna, Panagiota Papadopoulou, Bochuan Hu, Shuya Zang, Emma Wezenberg, Gabriel Forn-Cuní iD, Bruno Lopes-Bastos, Marianna Kruithof-de Julio, Alexander Kros iD und 1 weitere

ACS Nano · 2025

DOI: 10.1021/acsnano.4c14625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Gangyin Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Tumor Biology, Leiden Institute of Biology, Leiden University, Einsteinweg 55, Leiden 2333 CC, the Netherlands. Hauptthemen laut MEDLINE: Nanoparticles, Lipids, Peptides, RNA, Small Interfering. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesLipidsPeptidesRNA, Small InterferingAntineoplastic AgentsBreast NeoplasmsHumansAnimalsZebrafishFemaleCell Line, TumorCell ProliferationMaleMiceXenograft Model Antitumor AssaysLiposomes

Stichwörter der Autor:innen

CD44YAP/TAZ siRNAlipid nanoparticlespatient-derived PDXtumor targetingzebrafish

Substanzen

LipidsPeptidesRNA, Small InterferingAntineoplastic AgentsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Cellular Tumor Biology, Leiden Institute of Biology, Leiden University, Einsteinweg 55, Leiden 2333 CC, the Netherlands.
  • Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 51800, China.
  • Department of Supramolecular & Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, Leiden 2333 CC, the Netherlands.
  • Urology Research Laboratory, Department for BioMedical Research, University of Bern, Bern 3010, Switzerland.
  • Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.

ORCID-Profile: Gabriel Forn-Cuní, Alexander Kros

Förderung

  • China Scholarship Council

Zitieren

APA

Zhao, G., Zeng, Y., Cheng, W., Karkampouna, S., Papadopoulou, P., Hu, B., Zang, S., Wezenberg, E., Forn-Cuní, G., Lopes-Bastos, B., Julio, M. K., Kros, A., & Snaar-Jagalska, B. E. (2025). Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics. ACS Nano. https://doi.org/10.1021/acsnano.4c14625

Vancouver

Zhao G, Zeng Y, Cheng W, Karkampouna S, Papadopoulou P, Hu B, et al. Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics. ACS Nano. 2025. doi:10.1021/acsnano.4c14625

BibTeX
@article{Zhao2025,
  author = {Zhao, Gangyin and Zeng, Ye and Cheng, Wanli and Karkampouna, Sofia and Papadopoulou, Panagiota and Hu, Bochuan and Zang, Shuya and Wezenberg, Emma and Forn-Cuní, Gabriel and Lopes-Bastos, Bruno and Julio, Marianna Kruithof-de and Kros, Alexander and Snaar-Jagalska, B Ewa},
  title = {Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.4c14625}
}
Kostenlos starten →